694 related articles for article (PubMed ID: 34539656)
1. The Potential Roles of Mucosa-Associated Invariant T Cells in the Pathogenesis of Gut Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation.
Gao MG; Hong Y; Zhao XY; Pan XA; Sun YQ; Kong J; Wang ZD; Wang FR; Wang JZ; Yan CH; Wang Y; Huang XJ; Zhao XS
Front Immunol; 2021; 12():720354. PubMed ID: 34539656
[TBL] [Abstract][Full Text] [Related]
2. Reconstitution of Circulating Mucosal-Associated Invariant T Cells after Allogeneic Hematopoietic Cell Transplantation: Its Association with the Riboflavin Synthetic Pathway of Gut Microbiota in Cord Blood Transplant Recipients.
Konuma T; Kohara C; Watanabe E; Takahashi S; Ozawa G; Suzuki K; Mizukami M; Nagai E; Jimbo K; Kaito Y; Isobe M; Kato S; Takahashi S; Chiba A; Miyake S; Tojo A
J Immunol; 2020 Mar; 204(6):1462-1473. PubMed ID: 32041784
[TBL] [Abstract][Full Text] [Related]
3. Influence of post-transplant mucosal-associated invariant T cell recovery on the development of acute graft-versus-host disease in allogeneic bone marrow transplantation.
Kawaguchi K; Umeda K; Hiejima E; Iwai A; Mikami M; Nodomi S; Saida S; Kato I; Hiramatsu H; Yasumi T; Nishikomori R; Kondo T; Takaori-Kondo A; Heike T; Adachi S
Int J Hematol; 2018 Jul; 108(1):66-75. PubMed ID: 29582333
[TBL] [Abstract][Full Text] [Related]
4. Mucosal-associated invariant T cells predict increased acute graft-versus-host-disease incidence in patients receiving allogeneic hematopoietic stem cell transplantation.
Wang Z; Zhang S; Zhang X; Liu L; Zhou L; Shen Y; Zhang R; He Y; Yang D; Jiang E; Feng X; Zhou J; Cheng T; Han M; Feng S
Cancer Cell Int; 2022 Sep; 22(1):297. PubMed ID: 36180885
[TBL] [Abstract][Full Text] [Related]
5. Extracellular Vesicles Released from Human Umbilical Cord-Derived Mesenchymal Stromal Cells Prevent Life-Threatening Acute Graft-Versus-Host Disease in a Mouse Model of Allogeneic Hematopoietic Stem Cell Transplantation.
Wang L; Gu Z; Zhao X; Yang N; Wang F; Deng A; Zhao S; Luo L; Wei H; Guan L; Gao Z; Li Y; Wang L; Liu D; Gao C
Stem Cells Dev; 2016 Dec; 25(24):1874-1883. PubMed ID: 27649744
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity of Donor Natural Killer Cells to Allo-Reactive T Cells Are Related With Acute Graft-vs.-Host-Disease Following Allogeneic Stem Cell Transplantation.
Sheng L; Mu Q; Wu X; Yang S; Zhu H; Wang J; Lai Y; Wu H; Sun Y; Hu Y; Fu H; Wang Y; Xu K; Sun Y; Zhang Y; Zhang P; Zhou M; Lai B; Xu Z; Gao M; Zhang Y; Ouyang G
Front Immunol; 2020; 11():1534. PubMed ID: 32849519
[No Abstract] [Full Text] [Related]
7. Dental Biofilm Microbiota Dysbiosis Is Associated With the Risk of Acute Graft-
Heidrich V; Bruno JS; Knebel FH; de Molla VC; Miranda-Silva W; Asprino PF; Tucunduva L; Rocha V; Novis Y; Arrais-Rodrigues C; Fregnani ER; Camargo AA
Front Immunol; 2021; 12():692225. PubMed ID: 34220852
[TBL] [Abstract][Full Text] [Related]
8. γδ T Cells May Aggravate Acute Graft-Versus-Host Disease Through CXCR4 Signaling After Allogeneic Hematopoietic Transplantation.
Wu N; Liu R; Liang S; Gao H; Xu LP; Zhang XH; Liu J; Huang XJ
Front Immunol; 2021; 12():687961. PubMed ID: 34335589
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota intervention by pre and probiotics can induce regulatory T cells and reduce the risk of severe acute GVHD following allogeneic hematopoietic stem cell transplantation.
Yazdandoust E; Hajifathali A; Roshandel E; Zarif MN; Pourfathollah AA; Parkhideh S; Mehdizadeh M; Amini-Kafiabad S
Transpl Immunol; 2023 Jun; 78():101836. PubMed ID: 37037266
[TBL] [Abstract][Full Text] [Related]
10. Recent Metabolic Advances for Preventing and Treating Acute and Chronic Graft Versus Host Disease.
Mohamed FA; Thangavelu G; Rhee SY; Sage PT; O'Connor RS; Rathmell JC; Blazar BR
Front Immunol; 2021; 12():757836. PubMed ID: 34712243
[TBL] [Abstract][Full Text] [Related]
11. Circulating CD14(+) HLA-DR(-/low) myeloid-derived suppressor cells in leukemia patients with allogeneic hematopoietic stem cell transplantation: novel clinical potential strategies for the prevention and cellular therapy of graft-versus-host disease.
Yin J; Wang C; Huang M; Mao X; Zhou J; Zhang Y
Cancer Med; 2016 Jul; 5(7):1654-69. PubMed ID: 27109254
[TBL] [Abstract][Full Text] [Related]
12. CXCL12-CXCR4-Mediated Chemotaxis Supports Accumulation of Mucosal-Associated Invariant T Cells Into the Liver of Patients With PBC.
Chen Z; Liu S; He C; Sun J; Wang L; Chen H; Zhang F
Front Immunol; 2021; 12():578548. PubMed ID: 33815355
[No Abstract] [Full Text] [Related]
13. [Clinical characteristics of acute graft-versus-host disease confined solely to gastrointestinal tract after allogeneic hematopoietic stem cell transplantation].
Feng R; Liu DH; Xu LP; Chen H; Zhang XH; Han W; Zhao T; Liu KY; Huang XJ
Zhonghua Nei Ke Za Zhi; 2010 Dec; 49(12):1028-31. PubMed ID: 21211361
[TBL] [Abstract][Full Text] [Related]
14. A T-Cell Surface Marker Panel Predicts Murine Acute Graft-Versus-Host Disease.
Bäuerlein CA; Qureischi M; Mokhtari Z; Tabares P; Brede C; Jordán Garrote AL; Riedel SS; Chopra M; Reu S; Mottok A; Arellano-Viera E; Graf C; Kurzwart M; Schmiedgen K; Einsele H; Wölfl M; Schlegel PG; Beilhack A
Front Immunol; 2020; 11():593321. PubMed ID: 33584657
[TBL] [Abstract][Full Text] [Related]
15. Tyrosine supplement ameliorates murine aGVHD by modulation of gut microbiome and metabolome.
Li X; Lin Y; Li X; Xu X; Zhao Y; Xu L; Gao Y; Li Y; Tan Y; Qian P; Huang H
EBioMedicine; 2020 Nov; 61():103048. PubMed ID: 33039712
[TBL] [Abstract][Full Text] [Related]
16. Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.
Chaidos A; Patterson S; Szydlo R; Chaudhry MS; Dazzi F; Kanfer E; McDonald D; Marin D; Milojkovic D; Pavlu J; Davis J; Rahemtulla A; Rezvani K; Goldman J; Roberts I; Apperley J; Karadimitris A
Blood; 2012 May; 119(21):5030-6. PubMed ID: 22371885
[TBL] [Abstract][Full Text] [Related]
17. The expression of Th17-associated cytokines in human acute graft-versus-host disease.
Liu Y; Cai Y; Dai L; Chen G; Ma X; Wang Y; Xu T; Jin S; Wu X; Qiu H; Tang X; Li C; Sun A; Wu D; Liu H
Biol Blood Marrow Transplant; 2013 Oct; 19(10):1421-9. PubMed ID: 23792271
[TBL] [Abstract][Full Text] [Related]
18. Early gut microbiota signature of aGvHD in children given allogeneic hematopoietic cell transplantation for hematological disorders.
Biagi E; Zama D; Rampelli S; Turroni S; Brigidi P; Consolandi C; Severgnini M; Picotti E; Gasperini P; Merli P; Decembrino N; Zecca M; Cesaro S; Faraci M; Prete A; Locatelli F; Pession A; Candela M; Masetti R
BMC Med Genomics; 2019 Mar; 12(1):49. PubMed ID: 30845942
[TBL] [Abstract][Full Text] [Related]
19. Intestinal Microbiota at Engraftment Influence Acute Graft-Versus-Host Disease
Han L; Jin H; Zhou L; Zhang X; Fan Z; Dai M; Lin Q; Huang F; Xuan L; Zhang H; Liu Q
Front Immunol; 2018; 9():669. PubMed ID: 29740427
[TBL] [Abstract][Full Text] [Related]
20. Allogenic stem cell transplant-associated acute graft versus host disease: a computational drug discovery text mining approach using oral and gut microbiome signatures.
Beckman MF; Morton DS; Bahrani Mougeot F; Mougeot JC
Support Care Cancer; 2021 Apr; 29(4):1765-1779. PubMed ID: 33094358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
